Finance

Lists
Why is 190A down 4,62%?
Dive Deeper
190A:TYO
Chordia Therapeutics Inc
JP¥62,00
-4,62%
(-3,00) 1D
2 Okt., 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 190A...
Open
JP¥65
High
JP¥65
Low
JP¥61
Mkt. cap
4,79 mjd
Avg. vol.
574,18 k
Volume
1,24 m
52-wk high
JP¥179
52-wk low
JP¥61
EPS
-JP¥20
No. of employees
20
Open
JP¥65
High
JP¥65
Low
JP¥61
Mkt. cap
4,79 mjd
Avg. vol.
574,18 k
Volume
1,24 m
52-wk high
JP¥179
52-wk low
JP¥61
EPS
-JP¥20
No. of employees
20
News stories
From web sources and news partners
About Chordia Therapeutics Inc
CEO-
Employees20
Founded12 Okt. 2017
Headquarters-
Sector-
Websitechordiatherapeutics.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Aug. 2025
Nov. 2025
Feb. 2026
Mei 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
299,45 m
229,68 m
280,65 m
331,16 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,46 m
76,58 m
75,81 m
76,81 m
Operating expense
368,90 m
306,26 m
356,47 m
407,97 m
Total operating expenses
368,90 m
306,26 m
356,47 m
407,97 m
Operating income
-368,90 m
-306,26 m
-356,47 m
-407,97 m
Other non operating income
-13,68 m
16,43 m
18,16 m
-2,17 m
EBT including unusual items
-385,91 m
-294,85 m
-337,91 m
-413,51 m
EBT excluding unusual items
-385,91 m
-294,85 m
-337,91 m
-413,51 m
Income tax expense
605,00 k
475,00 k
475,00 k
475,00 k
Effective tax rate
-0,16%
-0,16%
-0,14%
-0,11%
Other operating expenses
-
-
-
-
Net income
-386,52 m
-295,32 m
-338,38 m
-413,98 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-368,23 m
-305,58 m
-355,79 m
-407,29 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme